Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Buprenorphine for Opiate Dependent Pain Patients
NCT00552578Phase 4Terminated
- Sponsor
- University at Buffalo
- Start
- Oct 2007
- Primary completion
- Oct 2008
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of buprenorphine in opioid use disorder (OUD) and chronic pain (2 arms), sponsored by University at Buffalo. Primary endpoint: Relapse to Substance Abuse at 6 months. Started Oct 2007; status: terminated.
02
Drugs
buprenorphine
03
Conditions
opioid use disorder (OUD)chronic pain
Beyond the preview
Go deeper on NCT00552578.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00552578.